NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for cardiotoxicity


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
California Stem Cell and Stemina Biomarker Discovery Announce Collaboration to Validate Effectiveness of Human Embryonic Stem Cell-Derived Cardiomyocyte Progenitors for Use in Predictive Toxicology
2009 SEP 28 ... that it can be used as a model system for investigating and predicting drug induced cardiotoxicity, officials from the firms announced. Stemina is a Madison, Wisconsin-based ...
Subject: California Stem Cell, Inc.
Price: $3.00
*
Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing
2009 SEP 28 ... industry consortium to validate a human cell model and analysis system for preclinical cardiotoxicity testing of pharmaceutical candidate compounds. The consortium will be formally launched ...
Subject: Cardiology
Price: $3.00
*
Clinical Data Evaluating Amrubicin(R) as Potential Therapy for Patients with Small Cell Lung Cancer Presented at 13th World Conference on Lung Cancer
2009 AUG 18 ... said Dr. Jotte. "Additionally, these data suggest that Amrubicin has an improved cardiotoxicity profile compared to traditional anthracyclines. We believe these results warrant further ...
Subject: Celgene Corporation
Price: $3.00
*
Data on breast cancer described by researchers at University of Cologne
2009 SEP 21 ... deviations from the planned chemotherapy schedule. There were no severe adverse events, cardiotoxicity or neutropenia. with negative estrogen or progesterone receptors, or high KI-67 suffered ...
Subject: Breast Cancer
Price: $3.00
*
Data on breast cancer detailed by E. Ahamed and co-authors
2009 OCT 12 ... of the drug even after disease progression in combination with chemotherapy. While cardiotoxicity Is well recognized with trastuzumab, unusual pulmonary toxicities are becoming ...
Subject: Breast Cancer
Price: $3.00
*
Investigators at University of British Columbia target cardiology
2009 SEP 14 ... British Columbia. The researchers concluded: "Troglitazone has potential cardiotoxicity at high doses but, at lower concentrations, does not prevent cardiac lipotoxicity, which ...
Subject: Cardiology
Price: $3.00
*
New apoptosis therapy study findings have been reported by researchers at Charles University, Department of Pharmacology
2009 SEP 7 ... new data in the report 'Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.' "Dexrazoxane ...
Subject: Apoptosis Therapy
Price: $3.00
*
New arrhythmia study findings have been published by scientists at Zagazig University
2009 SEP 7 ... exposed workers. Unprotected occupational exposure to chlorofluorocarbons can induce cardiotoxicity in the form of cardiac arrhythmias," wrote L.M.E. Sabik and colleagues, Zagazig ...
Subject: Arrhythmia
Price: $3.00
*
New breast cancer study findings recently were published by researchers at University of Freiburg
2009 NOV 2 ... This prospective open labeled, multicenter phase II study assessed the potential cardiotoxicity and efficacy of PLD and trastuzumab as first and second line combination therapy in ...
Subject: Breast Cancer
Price: $3.00
*
New findings from Y.S. Hua and co-authors in the area of necrosis published
2009 OCT 13 ... "Cardiotoxicity associated with ecstasy has been reported in recent years but is very rare. We described ...
Subject: Necrosis
Price: $3.00
*
New infarction study findings recently were published by S.Y. Lim and co-researchers
2009 NOV 23 ... the United Kingdom, "CB1 antagonism is associated with reduced doxorubicin-induced cardiotoxicity and decreased cerebrocortical infarction. Rimonabant, a selective CB1 receptor ...
Subject: Infarction
Price: $3.00
*
Reports from G. Fragasso et al highlight recent research in malaria
2009 NOV 9 ... Fragasso and colleagues published their study in Heart and Vessels (Cardiotoxicity after low-dose chloroquine antimalarial therapy. Heart and Vessels, 2009;24(5):385-387). ...
Subject: Malaria
Price: $3.00
*
Reports outline DNA research from Indiana University
2009 NOV 16 ... pools in perfused rat heart: implications for 3'-azido-3'-deoxythymidine-dependent cardiotoxicity. Biochemical Journal, 2009;422(Part 3):513-520). For additional ...
Subject: DNA Research
Price: $3.00
*
Reports summarize breast cancer study results from University of Manitoba
2009 SEP 28 ... to a study from Winnipeg, Canada, "The incidence and management of trastuzumab-mediated cardiotoxicity outside of clinical trials has not been well described. The aim of the study was to ...
Subject: Breast Cancer
Price: $3.00
*
Research from T. Sangeetha and co-researchers provides new data on heart attack
2009 SEP 7 ... the preventive role of S-allyl cysteine sulphoxide (SACS) in isoproterenol (ISO)-induced cardiotoxicity in male Wistar rats. Myocardial infarction was induced by subcutaneous injection of ISO ...
Subject: Heart Attack
Price: $3.00
*
Research on clinical trial research reported by E. Demirkaya et al
2009 NOV 23 ... used effectively in the treatment of several childhood malignancies. During treatment, cardiotoxicity caused by cell damage due to the free oxygen radicals that are generated is a major ...
Subject: Clinical Trial Research
Price: $3.00
*
Researchers from University of California publish new studies and findings in the area of cardiomyopathy
2009 NOV 9 ... expression of sarcomeric proteins, and increased tissue damage associated with Dox cardiotoxicity. Overexpression of CaMKII delta B in primary cardiac cells inhibits Dox-mediated ...
Subject: Cardiomyopathy
Price: $3.00
*
Studies from Children's Hospital update current data on pharmacological
2009 SEP 7 ... preliminary evaluation of in vivo toxicology revealed a significant dose related cardiotoxicity. Here we describe the improvement of pharmacological properties of thyroid hormone ...
Subject: Pharmacological
Price: $3.00
*
Study findings on cardiology are outlined in reports from S.K. Engle and colleagues
2009 OCT 5 ... measurements of in vivo target inhibition to demonstrate an off-target contribution to cardiotoxicity," wrote S.K. Engle and colleagues. The researchers concluded: "Additional ...
Subject: Cardiology
Price: $3.00
*
Study results from C.K. Chan and colleagues in the area of cancer published
2009 SEP 14 ... nor effective." "Chronic use of CsCl has resulted in cases with severe cardiotoxicity. report. A 65-year-old lady presented to our hospital's accident and emergency ...
Subject: Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login